Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease
Author:
Affiliation:
1. Department of Gastroenterology; Herlev Hospital; Herlev; Denmark
2. Institute for Inflammation Research; Rigshospitalet, University Hospital of Copenhagen; Copenhagen; Denmark
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12010/fullpdf
Reference34 articles.
1. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities;Hanauer;Inflamm Bowel Dis,2006
2. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006;Clark;Gastroenterology,2007
3. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects;Allez;J Crohns Colitis,2010
4. Assessing response and loss of response to biological therapies in IBD;Yanai;Am J Gastroenterol,2011
5. Serum sickness, encephalitis and other complications of anti-cytokine therapy;Vermeire;Best Pract Res Clin Gastroenterol,2009
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association of the TNFRSF1B rs1061622 variant with nonresponse to infliximab in ulcerative colitis;2023-09-27
2. Precision Medicine in Inflammatory Bowel Disease;Diagnostics;2023-08-29
3. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review;World Journal of Gastroenterology;2023-08-07
4. Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn’s disease patients;European Journal of Gastroenterology & Hepatology;2023-07-31
5. Identification of differentially expressed genes and enriched pathways in inflammatory bowel disease using bioinformatics and next generation sequencing data analysis;2023-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3